- Conditions
- Death, Sudden, Cardiac
- Interventions
- Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system
- Device
- Lead sponsor
- Kestra Medical Technologies, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 4
- States / cities
- Anchorage, Alaska • Ann Arbor, Michigan • St Louis, Missouri + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Cardiac Arrest, Sudden
- Interventions
- ASSURE™ Wearable Cardioverter Defibrillator (WCD)
- Device
- Lead sponsor
- Kestra Medical Technologies, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 10
- States / cities
- Anchorage, Alaska • Hammond, Louisiana • Takoma Park, Maryland + 7 more
- Conditions
- Sudden Cardiac Arrest
- Interventions
- Defibrillation
- Device
- Lead sponsor
- Kestra Medical Technologies, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 5,179 participants
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Seattle, Washington